Peroxisome proliferator-activated receptor (PPAR)-α, a redox-sensitive TF, is involved in lipid metabolism, and its agonists, such as fibrates, have been used in the clinic to reduce hypertriglyceridemia. Here, PPARA is linked to hypertriglyceridemia.